參考文獻 |
1. Modlich, U., J. Bohne, M. Schmidt, C. von Kalle, S. Knoss, A. Schambach, and C. Baum, Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood, 2006. 108(8): p. 2545-2553.
2. Sandmair, A.M., M. Vapalahti, and S. Yla-Herttuala, Adenoviruses as gene delivery vectors. Cancer Gene Therapy, 2002. 465: p. 423-429.
3. Gardlik, R., R. Palffy, J. Hodosy, J. Lukacs, J. Turna, and P. Celec, Vectors and delivery systems in gene therapy. Med Sci Monit, 2005. 11(4): p. RA110-121.
4. Feng Liu, L.H., Development of non-viralvectors for systemic gene delivery. Journal of Controlled Release, 2002. 78(1-3): p. 259-266.
5. Boussif, O., F. Lezoualch, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and J.P. Behr, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America, 1995. 92(16): p. 7297-7301.
6. Abdallah, B., L. Sachs, and B.A. Demeneix, Non-viral gene transfer: Applications in developmental biology and gene therapy. Biology of the Cell, 1995. 85(1): p. 1-7.
7. Zhao, Q.Q., J.L. Chen, T.F. Lv, C.X. He, G.P. Tang, W.Q. Liang, Y. Tabata, and J.Q. Gao, N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex. Biol. Pharm. Bull, 2009. 32(4): p. 706-710.
8. Chugh, A., F. Eudes, and Y.S. Shim, Cell‐penetrating peptides: Nanocarrier for macromolecule delivery in living cells. IUBMB Life, 2010. 62(3): p. 183-193.
9. Veldhoen, S., S.D. Laufer, A. Trampe, and T. Restle, Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide:quantitative analysis of uptake and biological effect. Nucleic Acids Research, 2006. 34(22): p. 6561–6573.
10. Bolhassani, A., Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochimica et Biophysica Acta, 2011. 1816: p. 232–246.
11. Mae, M. and Langel, U., Cell-penetrating peptides as vectors for
peptide, protein and oligonucleotide delivery. Current Opinion in
Pharmacology, 2006. 6: p. 509–514.
12. Baoum, A.A. and C. Berkland, Calcium condensation of DNA complexed with cell‐penetrating peptides offers efficient, noncytotoxic gene delivery. Journal of Pharmaceutical Sciences, 2011. 100(5): p. 1637–1642.
13. Baoum, A., S.X. Xie, A. Fakhari, and C. Berkland, “Soft” calcium crosslinks enable highly efficient gene transfection using tat peptide. Pharmaceutical Research, 2009. 26(12): p. 2619-2629.
14. Wang, H., C.Y. Zhong, J.F. Wu, Y.B. Huang, and C.B. Liu, Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide. Journal of Controlled Release, 2010. 143: p. 64-70.
15. Choosakoonkriang, S., B.A. Lobo, G.S. Koe, J.G. Koe, and C.R. Middaugh, Biophysical characterization of PEI/DNA complexes. Journal of Pharmaceutical Sciences, 2003. 92(8): p. 1710-1722.
16. Deng, R., Y. Yue, F. Jin, Y.C. Chen, H.F. Kung, M.C.M. Lin, and C. Wu, Revisit the complexation of PEI and DNA - How to make low cytotoxic and highly efficient PEI gene transfection non-viral vectors with a controllable chain length and structure? Journal of Controlled Release, 2009. 140(1): p. 40-46.
17. Zeng, X., Y.X. Sun, X.Z. Zhang, S.X. Cheng, and R.X. Zhuo, A Potential Targeting Gene Vector Based on Biotinylated Polyethyleneimine/Avidin Bioconjugates. Pharmaceutical Research, 2009. 26(8): p. 1931-1941.
18. Moghimi, S.M., P. Symonds, J.C. Murray, A.C. Hunter, G. Debska, and A. Szewczyk, A two-stage poly(ethylenimine)-mediated cytotoxicity: Implications for gene transfer/therapy. Molecular Therapy, 2005. 11(6): p. 990-995.
19. Varkouhi, A.K., M. Scholte, G. Storm, and H.J. Haisma, Endosomal escape pathways for delivery of biologicals. Journal of Controlled Release, 2010. 151(3): p. 1-9.
20. Wang, H., C.Y. Zhong, J.F. Wu, Y.B. Huang, and C.B. Liu, Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide. Journal of Controlled Release, 2010. 143: p. 64-70.
21. Cordeiro, M.F., G.S. Schultz, R.R. Ali, S.S. Bhattacharya, and P. T Khaw, Molecular therapy in ocular wound healing. British journal of ophthalmology, 1999. 83(11): p. 1219-1224.
22. Franceschi, R., Biological approaches to bone regeneration by gene therapy. Journal of dental research, 2005. 84(12): p. 1093-1103.
23. RH, J., BCbasics, 2007.
24. Tomlinson, E. and A. Rolland, Controllable gene therapy pharmaceutics of non-viral gene delivery systems. Journal of Controlled Release, 1996. 39(2): p. 357-372.
25. Crystal, R.G., Transfer of genes to humans: early lessons and obstacles to success. SCIENCE, 1995. 270(5235): p. 404-410.
26. De Smedt, S.C., J. Demeester, and W.E. Hennink, Cationic polymer based gene delivery systems. Pharmaceutical Research, 2000. 17(2): p. 113-126.
27. Nicolau, C., A. Le Pape, P. Soriano, F. Fargette, and M.F. Juhel, In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proceedings of the National Academy of Sciences, 1983. 80(4): p. 1068.
28. Wang, C.Y. and L. Huang, pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proceedings of the National Academy of Sciences, 1987. 84(22): p. 7851.
29. Ishikawa, Y. and C.J. Homcy, High efficiency gene transfer into mammalian cells by a double transfection protocol. Nucleic Acids Research, 1992. 20(16): p. 4367.
30. Douglas, K.L., C.A. Piccirillo, and M. Tabrizian, Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles. Journal of Controlled Release, 2006. 115(3): p. 354-361.
31. Moreira, C., H. Oliveira, L. Pires, S. Simoes, M. Barbosa, and A. Pęgo, Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone. Acta Biomaterialia, 2009. 5(8): p. 2995-3006.
32. Kircheis, R., L. Wightman, and E. Wagner, Design and gene delivery activity of modified polyethylenimines. Advanced drug delivery reviews, 2001. 53(3): p. 341-358.
33. Sagara, K. and S.W. Kim, A new synthesis of galactose-poly (ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. Journal of Controlled Release, 2002. 79(1): p. 271-281.
34. Wagner, E., M. Zenke, M. Cotten, H. Beug, and M.L. Birnstiel, Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proceedings of the National Academy of Sciences, 1990. 87(9): p. 3410.
35. Kircheis, R., A. Kichler, G. Wallner, M. Kursa, M. Ogris, T. Felzmann, M. Buchberger, and E. Wagner, Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene therapy, 1997. 4(5): p. 409.
36. Blessing, T., M. Kursa, R. Holzhauser, R. Kircheis, and E. Wagner, Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjugate chemistry, 2001. 12(4): p. 529-537.
37. Erbacher, P., J. Remy, and J. Behr, Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene therapy, 1999. 6(1): p. 138.
38. Hwa Kim, S., J. Hoon Jeong, K. Chul Cho, S. Wan Kim, and T. Gwan Park, Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly (ethylenimine). Journal of Controlled Release, 2005. 104(1): p. 223-232.
39. Kim, S.H., H. Mok, J.H. Jeong, S.W. Kim, and T.G. Park, Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjugate chemistry, 2006. 17(1): p. 241-244.
40. Lu, B., X.D. Xu, X.Z. Zhang, S.X. Cheng, and R.X. Zhuo, Low molecular weight polyethylenimine grafted N-maleated chitosan for gene delivery: properties and in vitro transfection studies. Biomacromolecules, 2008. 9(10): p. 2594-2600.
41. Jiang, H.L., Y.K. Kim, R. Arote, J.W. Nah, M.H. Cho, Y.J. Choi, T. Akaike, and C.S. Cho, Chitosan-graft-polyethylenimine as a gene carrier. Journal of Controlled Release, 2007. 117(2): p. 273-280.
42. Gao, J.Q., Q.Q. Zhao, T.F. Lv, W.P. Shuai, J. Zhou, G.P. Tang, W.Q. Liang, Y. Tabata, and Y.L. Hu, Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity. International journal of pharmaceutics, 2010. 387(1-2): p. 286-294.
43. Zhao, Q.Q., J.L. Chen, T.F. Lv, C.X. He, G.P. Tang, W.Q. Liang, Y. Tabata, and J.Q. Gao, N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex. Biological and Pharmaceutical Bulletin, 2009. 32(4): p. 706-710.
44. Kilk, K., S. El-Andaloussi, P. Jarver, A. Meikas, A. Valkna, T. Bartfai, P. Kogerman, M. Metsis, and U. Langel, Evaluation of transportan 10 in PEI mediated plasmid delivery assay. Journal of Controlled Release, 2005. 103(2): p. 511-523.
45. Wagner, E., M. Cotten, R. Foisner, and M.L. Birnstiel, Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proceedings of the National Academy of Sciences, 1991. 88(10): p. 4255.
46. Haensler, J. and F.C. Szoka Jr, Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate chemistry, 1993. 4(5): p. 372-379.
47. Parente, R.A., S. Nir, and F.C. Szoka Jr, Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry, 1990. 29(37): p. 8720-8728.
48. Wang, H., C.Y. Zhong, J.F. Wu, Y.B. Huang, and C.B. Liu, Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide. Journal of Controlled Release, 2010. 143(1): p. 64-70.
49. Lindgren, M., M. Hallbrink, A. Prochiantz, and U. Langel, Cell-penetrating peptides. Trends in pharmacological sciences, 2000. 21(3): p. 99-103.
50. Futaki, S., Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. International journal of pharmaceutics, 2002. 245(1): p. 1-7.
51. Schwarze, S.R., A. Ho, A. Vocero-Akbani, and S.F. Dowdy, In vivo protein transduction: delivery of a biologically active protein into the mouse. SCIENCE, 1999. 285(5433): p. 1569-1572.
52. Astriab-Fisher, A., D.S. Sergueev, M. Fisher, B. Ramsay Shaw, and R.L. Juliano, Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochemical pharmacology, 2000. 60(1): p. 83-90.
53. Josephson, L., C.H. Tung, A. Moore, and R. Weissleder, High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjugate chemistry, 1999. 10(2): p. 186-191.
54. Selsted, M.E., M.J. Novotny, W.L. Morris, Y.Q. Tang, W. Smith, and J.S. Cullor, Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. Journal of Biological Chemistry, 1992. 267(7): p. 4292-4295.
55. Zhang, L., A. Rozek, and R.E.W. Hancock, Interaction of cationic antimicrobial peptides with model membranes. Journal of Biological Chemistry, 2001. 276(38): p. 35714.
56. Hsu, J.C.Y. and C.M. Yip, Molecular dynamics simulations of indolicidin association with model lipid bilayers. Biophysical journal, 2007. 92(12): p. L100-L102.
57. Shaw, J.E., J.R. Alattia, J.E. Verity, G.G. Prive, and C.M. Yip, Mechanisms of antimicrobial peptide action: studies of indolicidin assembly at model membrane interfaces by in situ atomic force microscopy. Journal of structural biology, 2006. 154(1): p. 42-58.
58. Subbalakshmi, C., V. Krishnakumari, N. Sitaram, and R. Nagaraj, Interaction of indolicidin, a 13-residue peptide rich in tryptophan and proline and its analogues with model membranes. Journal of biosciences, 1998. 23(1): p. 9-13.
59. 林達翰, Indolicidin 及其類似物的聚集行為及其與仿生細胞膜間之交互作用, 2011.
60. Song, H.P., J.Y. Yang, S.L. Lo, Y. Wang, W.M. Fan, X.S. Tang, J.M. Xue, and S. Wang, Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide. Biomaterials, 2010. 31(4): p. 769-778.
61. Doyle, S.R. and C.K. Chan, Differential intracellular distribution of DNA complexed with polyethylenimine (PEI) and PEI-polyarginine PTD influences exogenous gene expression within live COS-7 cells. Genetic vaccines and therapy, 2007. 5(1): p. 11.
62. Rudolph, C., C. Plank, J. Lausier, U. Schillinger, R.H. Muller, and J. Rosenecker, Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. Journal of Biological Chemistry, 2003. 278(13): p. 11411.
63. Krohn, R.I., The Colorimetric Detection and Quantitation of Total Protein. Current Protocols in Food Analytical Chemistry, 2001: p. B1.1.1-B1.1.28.
64. Yang, S.T., S.Y. Shin, K.S. Hahm, and J.I. Kim, Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities. International journal of antimicrobial agents, 2006. 27(4): p. 325-330.
65. Florea, B.I., C. Meaney, H.E. Junginger, and G. Borchard, Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. The AAPS Journal, 2002. 4(3): p. 1-11.
66. Swami, A., A. Aggarwal, A. Pathak, S. Patnaik, P. Kumar, Y. Singh, and K.C. Gupta, Imidazolyl-PEI modified nanoparticles for enhanced gene delivery. International journal of pharmaceutics, 2007. 335(1-2): p. 180-192.
67. Zauner, W., N.A. Farrow, and A.M.R. Haines, In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. Journal of Controlled Release, 2001. 71(1): p. 39-51.
68. Akinc, A., M. Thomas, A.M. Klibanov, and R. Langer, Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis. The journal of gene medicine, 2005. 7(5): p. 657-663.
69. Yoshimori, T., A. Yamamoto, Y. Moriyama, M. Futai, and Y. Tashiro, Bafilomycin A1, a specific inhibitor of vacuolar-type H (+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. Journal of Biological Chemistry, 1991. 266(26): p. 17707-17712.
70. Ravi Kumar, M., G. Hellermann, R.F. Lockey, and S.S. Mohapatra, Nanoparticle-mediated gene delivery: state of the art. Expert opinion on biological therapy, 2004. 4(8): p. 1213-1224.
|